Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2010
11/11/2010WO2010129802A1 Inhibitors of jak
11/11/2010WO2010129665A2 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
11/11/2010WO2010129208A1 P38 kinase inhibiting agents
11/11/2010WO2010129053A2 Egfr inhibitors and methods of treating disorders
11/11/2010WO2010128685A1 Alpha helix mimetics and methods relating thereto
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2010127855A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/11/2010WO2010127452A1 5-oxo-ete receptor antagonist compounds
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010WO2009016498A8 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
11/11/2010US20100286410 Polymorphic Forms Of A 3-Pyrrole Substituted 2-Indolinone
11/11/2010US20100286407 Naphthalocyanine compound and method for producing the same
11/11/2010US20100286390 Pyridazinone compounds and p2x7 receptor inhibitors
11/11/2010US20100286353 Acetylene compound, salt thereof, condensate thereof, and composition thereof
11/11/2010US20100286173 Fungicide hydroximoyl-tetrazole derivatives
11/11/2010US20100286166 Compositions for the treatment of hyperphenylalaninemia
11/11/2010US20100286161 Pyrazine derivatives and their use as potassium channel modulators
11/11/2010US20100286160 Substituted piperazines as cb1 antagonists
11/11/2010US20100286158 Dihydropyrimidinones
11/11/2010US20100286157 4- [3- (4-cyclopropanecarbonyl-piperazine-i-carbonyl) -4 -fluoro-benzyl] -2h-phthalaz in-1-one
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/11/2010US20100286114 Hedgehog pathway antagonists and therapeutic applications thereof
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286008 Additive for oils and lubricant containing the same
11/11/2010US20100285515 specifically and efficiently detects pH change to emit fluorescence; used to detects pH change in deep tissue of a living body
11/11/2010US20100285075 Novel Hemioxalate Salt of Eletriptan
11/11/2010US20100284970 Benzimidazole modulators of h1 receptor and/or ns4b protein
11/11/2010CA2760794A1 Egfr inhibitors and methods of treating disorders
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2758289A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/10/2010EP2248806A2 Quinazoline derivatives as tyrosine kinase inhibitors
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP2247585A1 Crystal forms of n-ý2-(diethylamino)ethyl¨-5-ý(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl¨-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
11/10/2010EP2247580A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/10/2010EP2247579A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP1963309B1 Method for producing metal salts of losartan
11/10/2010EP1919908B1 Triazole derivatives as modulators of dopamine d3 receptors
11/10/2010EP1910316B1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
11/10/2010EP1589966B1 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1153613B1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
11/10/2010CN101883766A Process for the preparation of zolmitriptan, salts and solvates thereof
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101883764A Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101880274A Method for preparing tandospirone and analogues of tandospirone
11/09/2010US7829728 2-[(S)-1-(9-{Benzyl-1,2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-oxoethyl]-amino}nonyl)pyrrolidin-3-yl -2,2-diphenylacetamide; beta 2 adrenergic receptor agonist, muscarinic receptor antagonist activity; chronic obstructive pulmonary disease and asthma
11/09/2010US7829713 Therapeutic piperazines
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010US7829588 Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
11/09/2010US7829581 Prodrugs of pyrazoline compounds, their preparation and use as medicaments
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010CA2540845C Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010126851A1 Cxcr3 receptor antagonists
11/04/2010WO2010126270A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126045A1 Pyrazole-based cyanine dye containing quaternary ammonium cation
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125103A1 Diketopiperazine derivatives as p2x7 modulators
11/04/2010WO2010083215A3 Composition and method for the treatment of diseases affected by apoptosis
11/04/2010WO2010068863A3 Pyrimidine compounds and methods of making and using same
11/04/2010WO2010046804A3 A process for preparation of losartan potassium form i
11/04/2010WO2009090548A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/04/2010US20100280240 Bicyclic pyrazole compounds as antibacterial agents
11/04/2010US20100280192 Fast Curable Epoxy Compositions Containing Imidazole- And 1-(Aminoalkyl) Imidazole-Isocyanate Adducts
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280048 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280028 Cxcr3 receptor antagonists
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280012 Azaazulene compounds
11/04/2010US20100280011 Dual mechanism inhibitors for the treatment of disease
11/04/2010US20100280009 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279122 Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof
11/04/2010US20100278835 Novel compounds 660
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100276673 Organic compound, and organic photoelectric device including the same
11/04/2010CA2760071A1 New process and new compounds
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/03/2010EP2246370A1 Polymer compound and organic electroluminescent device using the same
11/03/2010EP2246347A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/03/2010EP2246346A1 Indolylmaleimide derivatives as protein kinase inhibitors
11/03/2010EP2246333A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/03/2010EP2245027A1 Hepatitis c virus inhibitors
11/03/2010EP2245026A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
11/03/2010EP2245017A2 Novel heterocycles
11/03/2010EP2245016A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
11/03/2010EP2001855B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 626